Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
13.49
+0.80 (6.30%)
At close: Oct 7, 2025, 4:00 PM EDT
13.59
+0.10 (0.74%)
After-hours: Oct 7, 2025, 5:43 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.44 billion as of October 7, 2025. Its market cap has increased by 581.78% in one year.
Market Cap
1.44B
Enterprise Value
1.26B
1-Year Change
581.78%
Ranking
Category
Stock Price
$13.49
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.44B, an increase of 34.58%. That is a compound annual growth rate of 8.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 1.44B | 459.14% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |